Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.015 USD | +1.27% | -3.59% | +8.33% |
Mar. 28 | Pulmatrix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 13 | Pulmatrix, Inc. Approves Termination of Margaret Wasilewski as Chief Medical Officer | CI |
Business Summary
Number of employees: 22
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Novel Class of Inhaled Therapeutic Products
100.0
%
| 6 | 100.0 % | 7 | 100.0 % | +20.21% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 6 | 100.0 % | 7 | 100.0 % | +20.21% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Teofilo Raad
CEO | Chief Executive Officer | 54 | 17-05-02 |
Peter Ludlum
DFI | Director of Finance/CFO | 68 | 22-04-17 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Batycky
BRD | Director/Board Member | 56 | 19-10-31 |
Director/Board Member | 54 | 20-06-22 | |
Todd Bazemore
BRD | Director/Board Member | 53 | 20-09-30 |
Anand Varadan
BRD | Director/Board Member | 57 | 21-07-25 |
Teofilo Raad
CEO | Chief Executive Officer | 54 | 17-05-02 |
Michael Higgins
CHM | Chairman | 61 | 15-06-14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 3,652,285 | 3,652,260 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.33% | 7.36M | |
-1.71% | 103B | |
+2.49% | 96.73B | |
+0.09% | 21.31B | |
-16.61% | 21.21B | |
-6.13% | 18.79B | |
-42.14% | 16.37B | |
-27.40% | 13.68B | |
+1.44% | 13.44B | |
+21.29% | 10.98B |
- Stock Market
- Equities
- PULM Stock
- Company Pulmatrix, Inc.